SynthesisFrontiers in oncology2022

What Is the Most Suitable Agent Combined With Apatinib for Transarterial Chemoembolization Treatment in Advanced Hepatocellular Carcinoma Patients? A Systematic Review and Network Meta-analysis.

Fuhai Hui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.